Showing results (1851-1860 of 2,185) with videos related to

Sort By:
Pageof 219
Prostate Cancer and Prostatic Diseases|February 22, 2024
Updated 5-year results for short course abiraterone acetate and LHRH agonist for unfavorable intermediate and favorable high-risk prostate cancerRyan E Fecteau, Bridget F Koontz, Karen E Hoffman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 28, 2018
Immune Biomarkers Predictive for Disease-Free Survival with Adjuvant Sunitinib in High-Risk Locoregional Renal Cell Carcinoma: From Randomized Phase III S-TRAC StudyDaniel J George, Jean-François Martini, Michael Staehler, et al.
Journal for Immunotherapy of Cancer|February 25, 2022
Safety and efficacy of nivolumab plus ipilimumab in patients with advanced non-clear cell renal cell carcinoma: results from the phase 3b/4 CheckMate 920 trialScott S Tykodi, Lucio N Gordan, Robert S Alter, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 12, 2004
Vaccination of cancer patients against telomerase induces functional antitumor CD8+ T lymphocytesRobert H Vonderheide, Susan M Domchek, Joachim L Schultze, et al.
Journal of Clinical and Translational Science|May 27, 2022
Telehealth and racial disparities in colorectal cancer screening: A pilot study of how virtual clinician characteristics influence screening intentionsEric J Cooks, Kyle A Duke, Jordan M Neil, et al.
Alimentary Pharmacology & Therapeutics|March 25, 2015
PNPLA3 rs738409 I748M is associated with steatohepatitis in 434 non-obese subjects with hepatitis CS Petta, E Vanni, E Bugianesi, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|December 16, 2021
Higher Angiotensin II Type 1 Receptor Levels and Activity in the Postmortem Brains of Older Persons with Alzheimer's DementiaCaglar Cosarderelioglu, Lolita S Nidadavolu, Claudene J George, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 16, 2019
Duration of Oxaliplatin-Containing Adjuvant Therapy for Stage III Colon Cancer: ASCO Clinical Practice GuidelineChristopher Lieu, Erin B Kennedy, Emily Bergsland, et al.
The Oncologist|June 8, 2021
Phase II Study of 5-Fluorouracil, Oxaliplatin plus Dasatinib (FOLFOX-D) in First-Line Metastatic Pancreatic AdenocarcinomaThomas J George, Azka Ali, Yu Wang, et al.
Archives of Physical Medicine and Rehabilitation|February 7, 2018
Turning Data Into Information: Opportunities to Advance Rehabilitation Quality, Research, and PolicyJanet Prvu Bettger, Vu Q C Nguyen, J George Thomas, et al.
Pageof 219